Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors study

Valladares Ayerbes, Manuel

Statistics

Statistics

View Usage Statistics

Identifiers

Identifiers

URI: http://hdl.handle.net/20.500.11940/7770

PMID: 22643538

DOI: 10.1634/theoncologist.2012-0048

ISSN: 1083-7159

Full record

Services

Services

RIS

Mendeley

Linksolver

Date issued

2012

Journal title

ONCOLOGIST

Type of content

Artigo